Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2003
08/07/2003WO2003064473A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
08/07/2003WO2003064472A2 Treatment of ms with goat serum
08/07/2003WO2003064457A1 A method for inhibiting 'melanoma inhibitory activity' mia
08/07/2003WO2003064456A1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
08/07/2003WO2003064455A2 Macrocyclic peptides active against the hepatitis c virus
08/07/2003WO2003064453A2 Trojan inhibitors, method for the production and use thereof
08/07/2003WO2003064448A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli
08/07/2003WO2003064447A2 Immune-modulating peptide
08/07/2003WO2003064441A2 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003WO2003064431A2 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
08/07/2003WO2003064430A1 Crystalline hydrochloride of 7-(((5-amino-1, 2, 4-thiadiazol-3-yl)(fluoromethoxyimino) acetyl) amino) -3- ((imino-1-piperazinylmethyl)methylhydrazono)-methyl-3-cephem-4-carboxylic acid
08/07/2003WO2003064422A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
08/07/2003WO2003064421A1 Aminopiperidine derivatives
08/07/2003WO2003064416A1 Heterocyclic tripeptides as hepatitis c inhibitors
08/07/2003WO2003064415A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064394A1 5-ring heterocycles used as antiviral agents
08/07/2003WO2003064383A2 Phosphorus-containing compounds & uses thereof
08/07/2003WO2003064378A2 Novel compounds that inhibit factor xa activity
08/07/2003WO2003063905A1 Preventives or remedies for immunological diseases
08/07/2003WO2003063901A1 Amino-substituted hypocrellins for use as sonosensitizers
08/07/2003WO2003063897A1 Method of providing prophylaxis for tuberculosis in hiv positive individuals
08/07/2003WO2003063888A1 Antiviral compositions and methods for identification and use
08/07/2003WO2003063877A1 Cefquinome composition for intra-mammary administration in cattle
08/07/2003WO2003063875A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063869A1 Anti-viral compounds
08/07/2003WO2003063864A2 Heterocyclic compounds which are active as inhibitors of beta lactamases
08/07/2003WO2003063863A1 Antibacterial pharmaceutical composition
08/07/2003WO2003063862A1 Cotherapy with an oxazolidinone and a vitamin b
08/07/2003WO2003063838A1 Dry granulated formulations of azithromycin
08/07/2003WO2003063837A1 Increased-dosage nelfinavir tablet and method of making same
08/07/2003WO2003063796A2 Heterocyclic arylsulfonamidobenzylic compounds
08/07/2003WO2003063792A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003WO2003063772A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003WO2003063771A2 N4-acylcytosine nucleosides for treatment of viral iinfections
08/07/2003WO2003063770A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/07/2003WO2003063767A2 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003WO2003063766A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003WO2003063725A2 Methods of preventing and treating flavivirus infection in animals
08/07/2003WO2003063573A2 Method for treating diseases with omega interferon
08/07/2003WO2003048375B1 Hybrid glycosylated products and their production and use
08/07/2003WO2002100415A3 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
08/07/2003WO2002068615A3 Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives
08/07/2003WO2002068476A3 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
08/07/2003WO2002055541A3 Peptides having inhibiting activity on the production of nitric oxide
08/07/2003WO2002051819A9 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
08/07/2003WO2002030259A9 Disease prevention by reactivation of the thymus
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149256 Transferrin polynucleotides, polypeptides, and antibodies
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030149114 Antiviral agents
08/07/2003US20030149113 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
08/07/2003US20030149108 Linked biaryl compounds
08/07/2003US20030149106 For use in moisturizing compositions (e.g., moisturizing skin treatments) to which medical adhesives will adhere, in tissue antiseptic preparations, in personal care forumulation such as cosmetics, and in drug delivery forumulations
08/07/2003US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
08/07/2003US20030149090 Topically delivering an effective dose of a reactvie oxygen metabolites (ROM) production and release inhibitory compound in carrier to a subject suffering from ROM-mediated oxidative damage
08/07/2003US20030149089 Antibacterial compounds
08/07/2003US20030149088 Antiviral agent
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149057 Anti-cancer compounds
08/07/2003US20030149055 Bicyclic compounds as inhibitors of chemokine binding to US28
08/07/2003US20030149051 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, cancer, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149040 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
08/07/2003US20030149037 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
08/07/2003US20030149035 For therapy and prophylaxis of infections by herpesviruses
08/07/2003US20030149031 For therapy of inflammation
08/07/2003US20030149026 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc.
08/07/2003US20030149016 Having wide range of anti-gram-positive and gram-negative microbial activities
08/07/2003US20030149014 Imidazo[4,5-b]-pyridinium-containing cephem compounds having broad antibacterial spectrum activity
08/07/2003US20030149010 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
08/07/2003US20030149001 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/07/2003US20030148985 Methods and reagents for the inhibition of hepatitis B virus replication
08/07/2003US20030148976 For therapy of cancer, infectious disease, and allergic disorders
08/07/2003US20030148967 For prophylaxis and therapy of viral infection for example by varicella zoster virus (VZV)
08/07/2003US20030148964 Single dose azithromycin
08/07/2003US20030148949 Administering a trefoil peptide or biologically active fragment thereof to a skin lesion or region of the skin where a lesion is to be prevented; wound healing agents which can speed healing, reduce pain and delay/prevent lesions
08/07/2003US20030148948 Super-active porcine growth hormone releasing hormone analog
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148945 Antimicrobial and anti-inflammatory peptides
08/07/2003US20030148941 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects
08/07/2003US20030148936 Bioactive peptides
08/07/2003US20030148926 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
08/07/2003US20030148516 Medium containing flt3 ligand for culturing hematophoietic cells
08/07/2003US20030148513 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
08/07/2003US20030148509 Retrovirus isolated from humans
08/07/2003US20030148465 Comprises membrane protein for diagnosis and treatment of atherosclerosis, viral and inflammatory diseases
08/07/2003US20030148456 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
08/07/2003US20030148346 Comprises Staphylococcus aureus virulence genes which target bactericides in assay; drug screening; vaccines
08/07/2003US20030148325 Infectious clones
08/07/2003US20030147978 A vaccine adjuvants and a growth promoter each comprising a sugar cane-derived extract as an active ingredient which agent is safe to man and animals. Also presented are foods and feeds comprising these agents.
08/07/2003US20030147970 Substantially non-colloidal solution made by combining ingredients comprising (a) water; (b) a source of free silver ions; and (c) a substantially non-toxic, substantially thiol-free, substantially water-soluble complexing agent.
08/07/2003US20030147937 Di-myo-inositol phosphate, cyclic 2,3 diphosphoglycerate, 1,1-di- glycerol phosphate, mannosylglycerate, mannosyl glyceramide and/or di-mannosyl-di-inositol phosphate; protecting organisms, organs, tissues, cells from oxidation
08/07/2003US20030147930 Antibiotic, functional cosmetic and functional food containing levulinic acid and their derivatives
08/07/2003US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof
08/07/2003US20030147922 Vaccine against streptococcus pneumoniae capsular polysaccharides
08/07/2003US20030147919 Producing empty, and thus non-infectious, parvovirus capsids, and to diagnostic assays and vaccines utilizing same; packaging and transferring nucleic acids
1 ... 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 ... 1798